| 1 |
30878191 | Novel nonapeptide GLP (28-36) amide derivatives with improved hypoglycemic and body weight lowering effects. | 2019 Apr 15 |
5 |
| 2 |
26178446 | Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice. | 2015 Dec |
1 |
| 3 |
24251641 | Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus. | 2014 May |
1 |
| 4 |
23117087 | Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach. | 2013 Jan 5 |
4 |
| 5 |
23466488 | Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats. | 2013 Apr 25 |
2 |
| 6 |
23571712 | GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro. | 2013 Jun 15 |
6 |
| 7 |
24023648 | Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats. | 2013 |
3 |
| 8 |
22147008 | Glucagon-like peptide-1 enhances glucokinase activity in pancreatic β-cells through the association of Epac2 with Rim2 and Rab3A. | 2012 Feb |
2 |
| 9 |
22414687 | GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity. | 2012 May |
5 |
| 10 |
22463807 | Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons. | 2012 Apr 1 |
1 |
| 11 |
25755995 | Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes. | 2012 |
1 |
| 12 |
21281062 | DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats. | 2011 Mar |
2 |
| 13 |
21362122 | Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes. | 2011 Jul |
1 |
| 14 |
21372151 | GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia. | 2011 May |
1 |
| 15 |
20206193 | GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats. | 2010 Jun 16 |
2 |
| 16 |
20227110 | Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat. | 2010 Aug |
2 |
| 17 |
20363879 | GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans. | 2010 Jun |
1 |
| 18 |
20582459 | Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart. | 2010 Jun |
2 |
| 19 |
18996945 | Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. | 2009 Feb |
1 |
| 20 |
19321133 | The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1. | 2009 May |
2 |
| 21 |
19453518 | Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. | 2009 Sep |
3 |
| 22 |
19497359 | Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats. | 2009 Jul 30 |
2 |
| 23 |
17976835 | Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. | 2008 Feb 7 |
3 |
| 24 |
18281111 | Differential inhibition of galanin- and ghrelin-induced food intake by i.c.v. GLP-1(7-36)-amide. | 2008 Apr 10 |
1 |
| 25 |
18424366 | N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity. | 2008 Feb 25 |
9 |
| 26 |
18502539 | Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus. | 2008 Aug |
4 |
| 27 |
18516352 | Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia. | 2008 Mar-Apr |
1 |
| 28 |
17125767 | Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. | 2007 Feb |
2 |
| 29 |
17581704 | Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. | 2007 Oct |
2 |
| 30 |
15718384 | Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. | 2005 Jun |
2 |
| 31 |
15930172 | Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. | 2005 Jun |
2 |
| 32 |
14759771 | N-acetyl-GLP-1: a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expression. | 2004 |
4 |
| 33 |
15005830 | Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. | 2004 Mar |
1 |
| 34 |
15093702 | Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. | 2004 Jun 15 |
2 |
| 35 |
15183115 | Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. | 2004 Jul 1 |
2 |
| 36 |
15469657 | Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. | 2004 Sep |
3 |
| 37 |
15536223 | S 23521 decreases food intake and body weight gain in diet-induced obese rats. | 2004 Oct |
1 |
| 38 |
12536013 | Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation. | 2003 Jan |
1 |
| 39 |
12624533 | Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system. | 2003 Feb |
2 |
| 40 |
12637035 | Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial hormone secretion induced by acute hyperosmotic challenge. | 2003 Feb |
4 |
| 41 |
12776726 | Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. | 2003 Jun |
3 |
| 42 |
12777949 | Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. | 2003 Jun |
1 |
| 43 |
12867498 | CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. | 2003 Jul 16 |
2 |
| 44 |
12967720 | Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. | 2003 Sep 26 |
4 |
| 45 |
14605997 | Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes. | 2003 Oct |
2 |
| 46 |
11812748 | Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. | 2002 Feb |
1 |
| 47 |
11834448 | Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat. | 2002 Feb |
1 |
| 48 |
11852032 | Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus. | 2002 Mar 1 |
7 |
| 49 |
11872668 | NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. | 2002 Mar |
1 |
| 50 |
11976797 | Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results. | 2002 May |
6 |